Samir Hanash
0000-0002-4210-1593
Publication & Citation Trends
Publications
0 total
Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancer
Cited by 0
Semantic Scholar
Lead time trajectory of blood-based protein biomarkers for detection of pancreatic cancer based on repeat testing.
Cited by 3
Semantic Scholar
Lung adenocarcinoma surfaceome remodeling with EGFR inhibitors uncovers placental alkaline phosphatase as a target for combination therapy
Cited by 1
Semantic Scholar
VALIDATION OF A BLOOD-BASED SPHINGOLIPID PANEL FOR MEN WITH LOCALIZED PROSTATE CANCER ON ACTIVE SURVEILLANCE
Cited by 0
Semantic Scholar
A novel method to guide biomarker combinations to optimize the sensitivity OA
Cited by 0
Semantic Scholar
MA02.08 Performance of A Blood-based Protein Biomarker Panel in the National Lung Screening Trial
Cited by 0
Semantic Scholar
Vesicle-mediated mitochondrial clearance underlies an actionable metabolic vulnerability in triple-negative breast cancer OA
Cited by 1
Semantic Scholar
Research Topics
interferon and immune responses
(185)
PARP inhibition in cancer therapy
(150)
Advanced Proteomics Techniques and Applications
(144)
RNA modifications and cancer
(133)
Glycosylation and Glycoproteins Research
(91)
Affiliations
University of Southern California
Cedars-Sinai Medical Center
Brigham and Women's Hospital
W.K. Kellogg Foundation
Tufts Medical Center